Incidence, clinical manifestations and characterization of Enterovirus in the last decade (2014-2023) in Asturias (Spain). Effect of the SARS-CoV-2 pandemic.

Publication date: Nov 15, 2024

Enteroviruses (EVs) are a large group of genotypes that cause a variety of pathologies, some of them very serious. This study analyzed the last 10 years (2014-2023) of EVs diagnosis and classification. In 166,674 samples collected, EVs were found in 9,535 (5. 7%) by rt-RT-PCR, and 332 (3. 5%) were classified by Sanger methods. Symptoms were analyzed in 7623 cases. EVs were found in 5718/63,829 (8. 9%) before, 1384/42,373 (3. 3%) during and 2433/60,472 (4%) after the Covid pandemic (p

Open Access PDF

Concepts	Keywords
Pandemic	Enterovirus
Pcr	Epidemiology
Spain	Genotyping
	Surveillance

Semantics

Type	Source	Name
disease	MESH	Infectious Diseases
drug	DRUGBANK	Coenzyme M
disease	MESH	Emergency
disease	MESH	syndromes
disease	MESH	common cold
disease	MESH	meningitis
disease	MESH	encephalitis
disease	MESH	paralysis
disease	MESH	death
disease	MESH	aseptic meningitis
disease	MESH	acute flaccid paralysis
disease	MESH	infections
disease	MESH	etiology
disease	IDO	infection
disease	IDO	nucleic acid
disease	MESH	viral load
disease	IDO	algorithm
disease	IDO	blood
disease	MESH	neurological manifestations
drug	DRUGBANK	Indoleacetic acid
drug	DRUGBANK	Pentaerythritol tetranitrate
disease	MESH	herpangina
disease	MESH	viral meningitis
disease	MESH	COVID 19
disease	IDO	quality
pathway	KEGG	Viral replication
disease	IDO	replication
disease	MESH	respiratory infections
drug	DRUGBANK	Cysteamine
disease	MESH	complications
drug	DRUGBANK	Carboxyamidotriazole
disease	MESH	Influenza
disease	MESH	polio
disease	MESH	Mouth Disease
disease	MESH	Echovirus infections
disease	MESH	tic
drug	DRUGBANK	Ribostamycin
pathway	REACTOME	Reproduction
disease	MESH	CNS infections
drug	DRUGBANK	Diflunisal

Original Article

(Visited 1 times, 1 visits today)